BeOne Medicines announces availability of 2026 interim report for six months ended June 30, 2026

PUBT · 3d ago
BeOne Medicines announces availability of 2026 interim report for six months ended June 30, 2026
  • BeOne Medicines AG filed a STAR Market interim report for the six months ended June 30, 2026.
  • The filing includes PRC GAAP disclosures on R&D expense allocations by key products, with a U.S. GAAP comparison.
  • The report was posted in Chinese on the Shanghai Stock Exchange website at https://www.sse.com.cn.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. BeOne Medicines AG published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001651308-26-000025), on August 26, 2026, and is solely responsible for the information contained therein.